Lenvenib 4 mg and 10 mg, manufactured by Sun Pharma, are oral anticancer medications containing Lenvatinib mesylate as the active ingredient. Lenvatinib is a multikinase inhibitor that targets several key receptor tyrosine kinases (RTKs) involved in tumor growth and angiogenesis—the process by which tumors develop their own blood supply to grow and spread. Specifically, it inhibits VEGF receptors (VEGFR1–3), FGFR (1–4), PDGFRα, RET, and KIT pathways, which are often overactive in various cancers.
Category | Anti Cancer Drugs |
Brand | Sun Pharma |
Ingredient | Lenvatinib |
Prescription Required | Yes |
Strength | 4/10mg |
Package | 7 Tablets |
Lenvenib 4 mg and 10 mg contain Lenvatinib mesylate, a powerful multikinase inhibitor that works by targeting multiple receptors involved in cancer cell growth and blood vessel formation. Specifically, it blocks vascular endothelial growth factor receptors (VEGFR 1–3), fibroblast growth factor receptors (FGFR 1–4), platelet-derived growth factor receptor alpha (PDGFRα), and RET and KIT pathways, which are often overactive in various types of cancer. By inhibiting these signaling pathways, Lenvenib prevents tumor cells from growing and spreading and disrupts the blood supply that tumors rely on for nourishment and oxygen.
Lenvenib 4 mg and 10 mg provide significant therapeutic benefits for patients with certain advanced cancers by targeting multiple pathways that contribute to tumor growth and blood vessel formation. As a multikinase inhibitor, Lenvenib works to block the signals that drive cancer cell proliferation and angiogenesis, helping to slow the progression of tumors.
The most common side effects of Lenvenib 4and 10 mg mg are
Other side effects of Lenvenib 4and 10 mg can include
Lenvenib 4 mg and 10 mg (Lenvatinib) should not be taken by individuals who are allergic to Lenvatinib or any of its components, as this may cause severe allergic reactions. It is also contraindicated in pregnant women because Lenvatinib may harm the unborn baby, and breastfeeding should be avoided during treatment, as the drug may pass into breast milk and pose risks to the infant.
Lenvenib 4 mg and 10 mg (Lenvatinib) should be taken exactly as prescribed by your healthcare provider. The capsules are taken orally, either with or without food, once daily at the same time each day to maintain consistency. Swallow the capsules whole with a glass of water—do not chew, crush, or open them. If you miss a dose and it’s been less than 12 hours, take it as soon as you remember; however, if it’s been more than 12 hours, skip the missed dose and take the next dose at your regular time.
There are no reviews yet.